Is Medtronic plc (MDT) Halal?
Shariah Screening — 5 Standards
Based on financial data from April 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 24.4% / 30% | 7.7% / 30% | 5.6% / 30% | 0.54% / 5% | ✓ HALAL |
| DJIM | 24.4% / 33% | 7.7% / 33% | 5.6% / 33% | 0.54% / 5% | ✓ HALAL |
| MSCI | 31.1% / 33% | 9.8% / 33% | 7.1% / 33% | 0.54% / 5% | ✓ HALAL |
| S&P | 24.4% / 33% | 7.7% / 33% | 5.6% / 33% | 0.54% / 5% | ✓ HALAL |
| FTSE | 31.1% / 33% | 9.8% / 33% | 7.1% / 50% | 0.54% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 65.2% | |
| Operating Margin | 20.0% | |
| Net Margin | 13.0% | |
| Return on Equity (ROE) | 9.4% | |
| Return on Assets (ROA) | 4.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $7.0B |
| Free Cash Flow | $5.2B |
| Total Debt | $28.5B |
| Debt-to-Equity | 57.1 |
| Current Ratio | 2.5 |
| Total Assets | $91.7B |
Price & Trading
| Last Close | $86.96 |
| 50-Day MA | $95.79 |
| 200-Day MA | $94.49 |
| Avg Volume | 8.1M |
| Beta | 0.7 |
|
52-Week Range
$79.55
| |
About Medtronic plc (MDT)
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Purification Calculator
As a halal stock with 0.54% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Medtronic plc (MDT) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Medtronic plc is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Medtronic plc's debt ratio?
Medtronic plc's debt ratio is 24.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 31.1%.
Does Medtronic plc require dividend purification?
Yes, Medtronic plc has an impermissible income ratio of 0.54%, which means 0.54% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Medtronic plc's key financial metrics?
Medtronic plc has a market capitalization of $111.9B, trailing P/E ratio of 24.3, and revenue of $33.5B. The company maintains a gross margin of 65.2% and a net margin of 13.0%. Return on equity stands at 9.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.